ELISA Kit for Asymmetrical Dimethylarginine (ADMA)
CEB301GE
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Asymmetrical Dimethylarginine (ADMA)
- Delivery Days Customer12
- Assay Detection Range12.35-1,000ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Asymmetrical Dimethylarginine (ADMA) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 4.99ng/mL
- Assay Test PrincipleThis assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Asymmetrical Dimethylarginine (ADMA) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin ...
- Assay Time2h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Merwid-Ląd A, Ziółkowski P, Szandruk-Bender M, et al. Effect of a Low Dose of Carvedilol on Cyclophosphamide-Induced Urinary Toxicity in Rats-A Comparison with Mesna. Pharmaceuticals (Basel). 2021,14(12). doi: 10.3390/ph14121237Read this paper
- Karahan I, Durmaz Ceylan S, Gungunes A, et al. Non-functioning adrenal incidentalomas may increase toxic metabolites. Wien Klin Wochenschr. 2022,134(3-4):125-129. doi: 10.1007/s00508-021-01909-9Read this paper
- Biel V, Novak J, Rimalova V, et al. Levels of endothelial substances in patients with newly identified hypertension compared with healthy controls. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021,165(4):395-401. doi: 10.5507/bp.2020.062Read this paper
- El Assar M, Fernández A, Sánchez-Ferrer A, et al. Multivessel analysis of progressive vascular aging in the rat: Asynchronous vulnerability among vascular territories. Mech Ageing Dev. 2018,173:39-49. doi: 10.1016/j.mad.2018.03.012Read this paper
- Shahin NN, Abdelkader NF, Safar MM. A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling. Sci Rep. 2018,8(1):4280. doi: 10.1038/s41598-018-22727-6Read this paper
- Reddy KRK, Dasari C, Duscharla D, et al. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA). Angiogenesis. 2018,21(1):79-94. doi: 10.1007/s10456-017-9587-0Read this paper
- Xuan C, Liu ZF, Wang Q, et al. Increased serum concentrations of asymmetric dimethylarginine (ADMA) in patients with early-onset coronary artery disease. Clin Chim Acta. 2017,464:195-199. doi: 10.1016/j.cca.2016.11.028Read this paper
- Xuan C, Xu LQ, Tian QW, et al. Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study. Sci Rep. 2016,6:33934. doi: 10.1038/srep33934Read this paper
- El Assar M, Angulo J, Santos-Ruiz M, et al. Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans. J Physiol. 2016,594(11):3045-60. doi: 10.1113/JP271836Read this paper
- Kim HY, Kim HS. Dimethylarginine dimethylaminohydrolase-1 mediates inhibitory effect of interleukin-10 on angiotensin II-induced hypertensive effects in vascular smooth muscle cells of spontaneously hypertensive rats. Cytokine. 2016,77:203-10. doi: 10.1016/j.cyto.2015.09.002Read this paper


